Harel Insurance Investments & Financial Services’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,000	Closed	-$65K	–	549
2019 Q1	$65K	Buy	10,000 +5,000	+100%	+$26.2K	﹤0.01%	251
2018 Q4	$25K	Buy	5,000 +2,000	+67%	+$14K	﹤0.01%	364
2018 Q3	$26K	Buy	3,000 +2,000	+200%	+$22.2K	﹤0.01%	407
2018 Q2	$13K	Buy	+1,000	New	+$13.7K	﹤0.01%	421

Other funds holding NTGN

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HMC

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Harel Insurance Investments & Financial Services's NTGN Position: Q2 2019 in Review

Harel Insurance Investments & Financial Services sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2019, closing a stake of 10,000 shares — an estimated $65K sold.

Harel Insurance Investments & Financial Services first reported a position in NTGN in Q2 2018 and held it in 4 quarters. The position peaked at $65K in Q1 2019. 51 funds tracked by Wall St. Rank hold NTGN as of Q2 2019.

Harel Insurance Investments & Financial Services reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Harel Insurance Investments & Financial Services sold 10,000 Neon Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $65K.
Harel Insurance Investments & Financial Services first reported a position in Neon Therapeutics, Inc. Common Stock in Q2 2018 and held it in 4 quarters.
Harel Insurance Investments & Financial Services's Neon Therapeutics, Inc. Common Stock position peaked at $65K in Q1 2019.
51 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2019, filed 22 Jul 2019.